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Abstract 
Background: Imported malaria is a frequent diagnosis in travellers and migrants. The objective of this study was to 
describe the epidemiological and clinical characteristics of patients diagnosed with imported malaria within a Spanish 
collaborative network registering imported diseases (+REDIVI). In addition, the possible association between malaria 
and type of case, gender, age or area of exposure was explored.
Methods: Cases of imported malaria were identified among all cases registered in the +REDIVI database during the 
period October 2009–October 2016. Demographic, epidemiological and clinical characteristics were analysed.
Results: In total, 11,816 cases of imported infectious diseases were registered in +REDIVI’s database between Octo‑
ber 2009 and October 2016. Immigrants seen for the first time after migration accounted for 60.2% of cases, 21.0% 
of patients were travellers, and 18.8% were travellers/immigrants visiting friends and relatives (VFRs). There were 
850 cases of malaria (850/11,816, 7.2%). Malaria was significantly more frequent in men than in women (56.8% vs 
43.2%) and in VFR‑immigrants (52.6%) as compared to travellers (21.3%), immigrants (20.7%) and VFR‑travellers (5.4%) 
(p < 0.001). Although this data was not available for most patients with malaria, only a minority (29/217, 13.4%) men‑
tioned correct anti‑malarial prophylaxis. Sub‑Saharan Africa was found to be the most common region of acquisition 
of malaria. Most common reason for consultation after travel was a febrile syndrome although an important propor‑
tion of immigrants were asymptomatic and presented only for health screening (27.3%). Around 5% of travellers pre‑
sented with severe malaria. The most prevalent species of Plasmodium diagnosed was Plasmodium falciparum (81.5%). 
Malaria due to Plasmodium ovale/Plasmodium vivax was frequent among travellers (17%) and nearly 5% of all malaria 
cases in immigrants were caused by Plasmodium malariae.
Conclusions: Malaria was among the five most frequent diagnoses registered in +REDIVI’s database. Some sig‑
nificant differences were found in the distribution of malaria according to gender, type of case, species. Among all 
malaria cases, the most frequent diagnosis was P. falciparum infection in VFR‑immigrant men.
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Background
According to the World Health Organization, between 
2000 and 2015 there has been a 37% global decrease in 
malaria incidence and a 60% decrease in global mortal-
ity rates. However, in 2015 there were still an estimated 
212 million malaria cases worldwide [1]. In the last 
decade, a decrease in the overall incidence of imported 
malaria has also been registered in most European coun-
tries although data from specialized travel networks have 
shown an increase in malaria cases during specific time 
periods [2, 3]. Specific groups appear more vulnerable, 
such as travellers visiting friends and relatives (VFRs), 
who account for the majority of imported malaria cases 
as documented in several studies [4, 5]. Malaria is poten-
tially fatal especially in non-immune travellers and a 
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favourable outcome is associated with timely diagno-
sis and initiation of specific correct treatment. Malaria 
transmission in non-endemic areas is infrequent, 
although isolated cases of congenital, transfusion and 
transplantation-associated malaria have been described 
[6–9]. Vector-borne transmission in non-endemic areas 
is unlikely but possible if, due to global climate changes, 
competent Anopheles species are introduced and become 
established in new areas. Imported malaria could lead to 
autochthonous cases if competent vectors are present in 
specific areas. Awareness and surveillance of imported 
malaria is essential for the individual patient and from a 
public health point of view.
The objective of this study was to describe the epidemi-
ological and clinical characteristics of patients diagnosed 
with imported malaria within the +REDIVI network. 
The possible association between malaria and type of 
case, gender, age or area of exposure were explored.
Methods
An observational prospective study included patients 
diagnosed with malaria and registered in the +REDIVI 
Collaborative Network during the period October 2009 
to October 2016. The methodology used for +REDIVI 
has been previously published [10]. This national network 
includes 25 centres which share a common online data-
base where new cases of imported infectious diseases are 
prospectively registered. A data collection sheet is filled 
out online by all members and a unique identifier code 
is automatically generated for each new case. Ill returned 
travellers/immigrants may account for more than one 
case in the database if a new diagnosis of an imported 
infectious disease is associated with a different trip. A 
coordinating centre is in charge of database management 
and quality assessment as well as ensuring proper com-
pliance with a pre-defined protocol, which includes test-
ing for malaria with the polymerase chain reaction (PCR) 
in sub-Saharan African immigrants even if asymptomatic 
in most centres. Ethics approval was obtained from the 
coordinating centre’s ethics committee and for all centres 
which requested it.
Variables for demographic characteristics included 
date of birth, gender, country of birth and main country 
of residence during the last 5  years. Clinical and epide-
miological data included type of immunosuppression if 
applicable, type of traveller, date of first arrival in Spain, 
length of travel, date of return from travel, travel destina-
tion or country of origin for immigrants, travel risk level, 
pre-travel consultation attendance, indication for malaria 
prophylaxis, specific drug if prescribed and whether it 
was correctly taken. +REDIVI includes immigrants (per-
son living in Spain but born in any other country), VFR-
immigrants (immigrant travelling back from country 
of birth after visiting friends and relatives), VFR-travel-
lers (person who travels back from his/her first-degree 
relative’s country of birth) and travellers (conventional 
international tourists returning from travel). In order to 
classify the cases, 519 diagnostic codes and 22 types of 
syndromes were available in +REDIVI.
A descriptive analysis was performed in order to assess 
gender distribution, age, type of case (immigrants, VFR-
immigrants, VFR-travellers or travellers), time to presen-
tation after travel, immunosuppression status, duration 
of travel, pre-travel advice, main presenting complaints 
and main diagnoses. Qualitative variables were expressed 
as relative and absolute frequencies, and quantitative data 
were expressed as median and 25th and 75th percentiles. 
Ninety-five percent confidence intervals were calculated. 
The  Chi2 and Fischer exact test were used when appro-
priate for comparison of categorical variables. Con-
tinuous variables were compared using Student’s t test 
(when normally distributed) or the Mann–Whitney U 
test (when data were not normally distributed) and the 
analysis of variances (ANOVA) when several categories 
existed within a continuous variable.
Results
In total, 11,816 cases of imported infectious diseases 
were diagnosed in +REDIVI between October-2009 and 
October-2016. Of these, 6289 (53.2%) cases occurred in 
women. The database included 2479 travellers (21.0%), 
218 VFR-travellers (1.9%), 2001 VFR-immigrants (16.9%), 
and 7118 immigrants (60.2%). Most prevalent diagnoses 
in +REDIVI were Chagas disease (27.1%), eosinophilia 
(17.4%), strongyloidiasis (9.2%), latent tuberculosis (8.5%) 
and malaria (7.2%). For all other diagnoses, prevalence 
was below 5%.
In total, 850 cases of malaria (7.2%) were identified 
among the 11,816 registers. Malaria cases were signifi-
cantly higher (p < 0.001) among men (56.8%) than among 
women (43.2%). Median age was 35.6 (27.9–44.0) years 
and there were 45 (5.3%) immunosuppressed patients 
among malaria cases. Malaria cases were not associ-
ated with age or immunosuppression status. Malaria 
cases were especially prevalent among VFR-immigrants 
as compared to other types of cases: more than 50% of 
malaria infections were in VFR-immigrants (p  <  0.001). 
As for duration of travel, this was significantly longer 
in travellers than in VFRs (p  <  0.001). Finally, median 
elapsed time between arrival and first consultation was 
higher for immigrants than for other types of patients 
(p < 0.001) (Table 1).
As for regions of acquisition of malaria, cases were 
mainly acquired in sub-Saharan Africa. However, among 
travellers, a proportion of cases were associated with 
travel to Latin America and Asia (5.0% for both). The 
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most prevalent species of malaria was P. falciparum in 
the four groups (693/850, 81.5%). If species and geo-
graphic distribution are considered, the most frequent 
diagnosis was Plasmodium falciparum diagnosed in 
VFR-immigrants from sub-Saharan Africa. Malaria due 
to Plasmodium ovale/Plasmodium vivax, was frequent 
among travellers (17%) and nearly 5% of all malaria cases 
in immigrants were caused by Plasmodium malariae 
acquired in sub-Saharan Africa. Severe malaria cases 
were especially prevalent in travellers (5.5%) (p =  0.01). 
No fatal cases were recorded (Table 2).
Information on whether anti-malarial prophylaxis had 
been taken correctly was only available for 1050 cases 
in the database. For patients with malaria, this informa-
tion was recorded for only 217 (25.5%) out of the 850 
cases and 29 out of 217 (13.4%) travellers/VFR travellers/
VFR immigrants referred having taken the medication 
correctly. As expected, the percentage of patients refer-
ring correct anti-malarial prophylaxis was significantly 
(p  <  0.001) lower among malaria cases (13.4%) than 
among non-malaria cases (46.1%).
Considering only the subgroup of travellers with P. 
ovale/P. vivax malaria, these patients had taken malaria 
chemoprophylaxis correctly significantly more frequently 
than those with non-P. ovale/P. vivax malaria (35.5%, 
11/31 vs 2.7%, 4/150, p < 0.001). Among travellers with P. 
ovale/P. vivax malaria who had taken correct prophylaxis, 
45.5% (5/11) had taken atovaquone–proguanil and 27.3% 
had taken mefloquine (3/11). Travellers with P. ovale/P. 
vivax malaria presented a median of 47  days (9–121) 
after travel whereas travellers with non-P. ovale/P. vivax 
malaria presented after a median of 9  days (3.75–21), 
although this difference was not statistically significant 
(p = 0.79).
With regards to reasons for medical consultation after 
travel, most patients with malaria (79.8%) presented 
with only one syndrome regardless of the type of patient 
(p =  0.79). Although the most frequent reason for con-
sultation for the four groups was a febrile syndrome, a 
substantial percentage of immigrants (48/176, 27.3%) 
presented with no symptoms, for health screening only. 
Of note, 9/447 VFR-immigrants (2%) and one traveller 
(originally from Burkina Faso but travelled to Haiti) were 
also asymptomatic at presentation.
Discussion
Imported malaria may still be considered a significant 
entity in non-endemic countries. A recent review high-
lighted this problem especially when considering the cur-
rent international goal for global malaria eradication: the 
meta-analysis of imported malaria in the last decade cov-
ering more than 50,000 individual cases identified France 
and the UK as the countries receiving the highest number 
of cases, with over 4000 reported cases yearly on average 
Table 1 Main characteristics of malaria cases
p  Chi2 p value for categorical variables, Student’s T test p value for continuous variables and analysis of variance (ANOVA) for continuous variables with several 
categories, NA not applicable
MALARIA p
n = 850 
Women (n,  %) 367 43.2 < 0.001
Age (median,  P25–P75) 35.6 27.9–44.0 0.57
Immunosuppression (n, %) 45 5.3 0.52
Type of case (n, %) < 0.001
 Immigrants 176 20.7
 VFR‑immigrants 447 52.6
 VFR‑travellers 46 5.4
 Travellers 185 21.3
Travel duration in days (median,  P25–P75) < 0.001
 Immigrants NA
 VFR‑immigrants 30 24–61.3
 VFR‑travellers 48 30–120
 Travellers 60 25–240
Elapsed time between arrival and consultation in days (median,  P25–P75) < 0.001
 Immigrants 16.5 7–77
 VFR‑immigrants 11 6–20
 VFR‑travellers 13 5.8–20.5
 Travellers 10 4–27
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[11]. This current series underscores this issue as over 
120 yearly cases on average were registered within this 
national network and imported malaria was among the 
top five established diagnoses. According to WHO data, 
there was an average of 500 imported cases of malaria per 
year in Spain between the years 2009 and 2015 [12]. Even 
accounting for possible under-reporting at the national 
level of official epidemiological surveillance data for com-
municable diseases, the +REDIVI Collaborative Network 
provides additional data on a significant proportion of all 
imported malaria cases in Spain. This is an established 
network in Spain and although not all centres attending 
imported infections are included, data on over 11,000 
patients were available for analysis. With respect to other 
similar series such as the Geosentinel network, a higher 
proportion of malaria cases were diagnosed in +REDIVI 
(7.2% of all diagnoses compared with 2% in the Geosenti-
nel series) although this may be due to the fact that both 
symptomatic and asymptomatic patients were included 
and there was a greater representation of immigrants 
(both VFR-immigrants and conventional immigrants) in 
the current analysis (VFRs accounted for 15% of travel-
lers in the Geosentinel series) [13].
VFRs are a high risk group for malaria. This has been pre-
viously documented in other series where these travellers 
account for more than 70% of malaria cases in some stud-
ies [4, 5]. In this study, malaria was significantly more fre-
quent in VFR-immigrants with more than 50% of malaria 
infections diagnosed in this group, even though the median 
duration of travel was shorter than for travellers, probably 
reflecting the higher risk associated with VFR travel.
Pre-travel advice and preventive measures should 
therefore be especially directed to this group. Interest-
ingly, no cases of malaria were seen in short-term trav-
ellers (<  25  days) and occurred mainly in medium-long 
term travellers in this group (probably higher risk sub-
groups of travellers such as aid workers and expatriates). 
Of concern, malaria chemoprophylaxis continues to be 
poorly adhered to. A longer elapsed time from arrival to 
consultation was found for immigrants probably reflect-
ing a degree of semi-immunity (some of these patients 
were asymptomatic). The most frequently diagnosed case 
was in VFR- immigrants with P. falciparum imported 
from sub-Saharan Africa and this finding is similar to 
that found in other series identifying these patients as 
high risk [4]. An important proportion of non-falcipa-
rum imported malaria was also found in the study (9%, 
not including mixed infections and infections where spe-
cies was not determined), mainly due to P. ovale/P. vivax 
malaria in travellers. Although this data was not available 
for most patients with malaria, only a minority (13.4 %) 
mentioned correct anti-malarial prophylaxis. Of note, 
travellers with P. ovale/P. vivax malaria presented later 
than those with non-P. ovale/P. vivax malaria and in some 
cases despite referring “correct” anti-malarial prophy-
laxis (due to a lack of a causal effect of the drugs used). 
Table 2 Geographical distribution by type of case and distribution of malaria species and severe malaria by type of case
No cases were acquired in Europe, Australasia-Oceania, North Africa or North America
Immigrants VFR-immigrants VFR-travellers Travellers
N = 176 N = 447 N = 46 N = 181
n % n % n % n %
Subsaharan Africa 168 95.5 433 96.9 45 97.8 163 90.0
 P. falciparum 140 83.3 380 87.8 39 86.7 123 75.5
 P. malariae 8 4.8 5 1.2 1 2.2 1 0.6
 P. ovale 4 2.4 7 1.6 2 4.4 14 8.6
 P. vivax 2 1.2 0 0.0 0 0.0 7 4.3
 Unknown 10 6.0 29 6.7 1 2.2 14 8.6
 Mixed infection 4 2.4 12 2.8 2 4.4 4 2.5
Central and South America 2 1.1 9 2.0 0 0.0 9 5.0
 P. falciparum 0 0.0 3 33.3 0 0.0 4 44.4
 P. ovale 0 0.0 0 0.0 0 0.0 1 11.1
 P. vivax 2 100.0 5 55.6 0 0.0 3 33.3
 Unknown 0 0.0 1 11.1 0 0.0 1 11.1
Asia 6 3.4 5 1.1 1 2.2 9 5.0
 P. falciparum 0 0.0 2 40.0 0 0.0 2 22.2
 P. vivax 5 83.3 3 60.0 1 100.0 6 66.7
 Unknown 1 16.7 0 0.0 0 0.0 1 11.1
Severe malaria 2 1.1 6 1.3 1 2.2 10 5.5
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This should alert clinicians to the possibility of infections 
which may not be easily diagnosed due to later presen-
tation even with correct chemoprophylaxis use [14, 15]. 
In addition, these infections may be missed if only rapid 
diagnostic tests are used [16].
As expected, the most frequent presenting symptom 
for all groups was fever, underscoring the importance 
of recognizing the possibility of malaria in any person 
returning from an endemic area with fever in order to 
minimize diagnostic delay. According to ECDC sur-
veillance data for 2014, approximately 5200 cases of 
imported malaria occur in EU countries annually [17], 
and around 1/3 of falciparum malaria cases may progress 
to severe malaria [18]. In this series around 5% of trav-
ellers presented with severe malaria, but this figure was 
lower (19/850, 2.2%) if all groups are considered probably 
reflecting the large proportion of immigrants in the study 
who may have a degree of semi-immunity. In fact, over 
5% of malaria cases were diagnosed in asymptomatic 
immigrants, as nucleic acid testing by PCR has proven a 
sensitive method for screening, detecting infections with 
low parasite densities which are not infrequent in this 
group [19]. Detection of submicroscopic infections is 
relevant as low-grade asymptomatic parasitaemias have 
been described to persist for over 24 months in recently 
arrived immigrants. These persons may infect competent 
vectors in non-endemic areas acting as unidentified res-
ervoirs and contributing to transmission in areas where 
malaria has been eliminated [20]. Anopheles atroparvus, 
a competent vector for Asian strains of P. vivax, is widely 
distributed in Spain. A recent publication has reported 
an autochthonous case of introduced malaria caused by 
P. vivax in Spain in 2014, where the strain was identical 
to that of another imported case from Pakistan [21]. In 
2010, another autochthonous case of P. vivax malaria 
was diagnosed in a patient with no history of travel to 
endemic areas. The patient lived in an area where the 
vector An. atroparvus is present but the source of the 
infection could not be identified [22]. Local transmis-
sion of malaria should be very infrequent as the num-
ber of yearly imported P. vivax cases in Spain is low (an 
estimated < 50/year) and An. atroparvus is refractory to 
African strains of P. falciparum [21]. However, P. vivax 
gametocytes develop early in the course of infection 
and this species can produce liver hypnozoites causing 
relapses and, therefore, the risk of vector-borne trans-
mission exists. In addition, if other competent Anopheles 
species are introduced due to climate change and become 
established in non-endemic areas the risk of local trans-
mission may be increased. Although rare, congenital 
transmission or transmission by blood transfusion or 
organ transplantation from an infected donor could also 
occur years after leaving malaria-endemic areas.
Plasmodium falciparum was the most frequently diag-
nosed species in the series. This is in accordance with 
global prevalence of this species and also with other 
reports of imported malaria where P. falciparum is the 
most commonly reported species among imported cases 
of malaria, mainly in patients returning from sub-Saha-
ran Africa [2]. Severe malaria cases occurred mainly 
in travellers highlighting the need for early diagnosis in 
non-immune patients.
Limitations of the study were that the data was col-
lected mainly at specialised travel clinics and all cases of 
imported malaria nationally were not included, thus pre-
cluding a more complete overview of imported malaria 
in Spain during the study period. Also, the network 
recorded the main clinical and epidemiological data but 
more detailed information such as specific laboratory 
parameters for particular cases was not included and 
some data, such as chemoprophylaxis use, was not avail-
able for all patients.
Conclusions
Malaria is a frequent diagnosis in returning travellers. 
Significant differences may be found in the distribution 
of malaria according to gender, type of case and species. 
Among all malaria cases, the most frequent diagnosis 
was P. falciparum infection in VFR-immigrants acquired 
in sub-Saharan Africa. Immigrants, VFR-travellers and 
travellers with malaria also presented mainly with P. fal-
ciparum infections from sub-Saharan Africa. However, P. 
ovale and P. vivax infections were also prevalent among 
travellers. This highlights the need for specialized, indi-
vidually patient-tailored pre-travel advice.
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